Literature DB >> 12113422

Laparoscopic total mesorectum excision.

J A Reis Neto1, F A Quilici, F Cordeiro, J A Reis, O Kagohara, J Simões Neto.   

Abstract

The main controversy of colon-rectal laparoscopic surgery comes from its use as a cancer treatment. Two points deserve special attention: the incidence of port-site tumor implantation and the possibility of performing radical cancer surgery, such as total mesorectum excision. Once these points are addressed, the laparoscopic approach will be used routinely to treat rectal cancer. To clarify these points, 32 patients with cancer of the lower rectum participated in a special protocol that included preoperative radiotherapy and laparoscopic total mesorectum excision. All data were recorded. At the same time, all data recorded from the experience of a multicenter laparoscopic group (Brazilian Colorectal Laparoscopic Surgeons - 130 patients with tumor of the lower rectum) were analyzed and compared with the data provided by our patients. Analysis of the results suggests that a laparoscopic approach allows the same effective resection as that of conventional surgery and that preoperative irradiation does not influence the incidence of intraoperative complications. The extent of lymph nodal excision is similar to that obtained with open surgery, with an average of 12.3 lymph nodes dissected per specimen. The rate of local recurrence was 3.12%. No port site implantation of tumor was noted in this series of patients with cancer of the lower rectum.

Entities:  

Mesh:

Year:  2002        PMID: 12113422      PMCID: PMC3043413     

Source DB:  PubMed          Journal:  JSLS        ISSN: 1086-8089            Impact factor:   2.172


  10 in total

1.  Laparoscopic bowel resection: advantages and limitations.

Authors:  S D Wexner; O B Johansen
Journal:  Ann Med       Date:  1992-04       Impact factor: 4.709

2.  Recurrence and survival after total mesorectal excision for rectal cancer.

Authors:  R J Heald; R D Ryall
Journal:  Lancet       Date:  1986-06-28       Impact factor: 79.321

3.  Pre-operative radiotherapy in rectal cancer: evaluation of irradiation effects on cellular undifferentiation and its influence on prognosis.

Authors:  J A Reis Neto; F A Quilici; F Cordeiro; S Ciquini; J A Reis
Journal:  Hepatogastroenterology       Date:  1999 Sep-Oct

4.  Minimally invasive colon resection (laparoscopic colectomy).

Authors:  M Jacobs; J C Verdeja; H S Goldstein
Journal:  Surg Laparosc Endosc       Date:  1991-09

5.  Preoperative radiotherapy for colorectal cancer.

Authors:  G A Higgins; J H Conn; P H Jordan; E W Humphrey; B Roswit; R J Keehn
Journal:  Ann Surg       Date:  1975-05       Impact factor: 12.969

6.  Radical external beam radiation therapy for adenocarcinoma of the rectum.

Authors:  B J Cummings; W D Rider; A R Harwood; T J Keane; G M Thomas
Journal:  Dis Colon Rectum       Date:  1983-01       Impact factor: 4.585

7.  Mesorectal excision for rectal cancer.

Authors:  J K MacFarlane; R D Ryall; R J Heald
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

8.  Laparoscopic-assisted abdominoperineal resection with pull-through (sphincter saving).

Authors:  L H Kim; K E Chung; P AuBuchon
Journal:  Surg Laparosc Endosc       Date:  1992-09

9.  A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma. A 10-year randomized trial.

Authors:  J A Reis Neto; F A Quilici; J A Reis
Journal:  Dis Colon Rectum       Date:  1989-08       Impact factor: 4.585

10.  New prospects in the conservative treatment of rectal cancer.

Authors:  J Papillon
Journal:  Dis Colon Rectum       Date:  1984-11       Impact factor: 4.585

  10 in total
  2 in total

1.  Laparoscopic surgery--15 years after clinical introduction.

Authors:  Reinhard Bittner
Journal:  World J Surg       Date:  2006-07       Impact factor: 3.352

2.  Laparoscopic versus conventional open resection of rectal carcinoma: A clinical comparative study.

Authors:  Wen-Xi Wu; Yao-Min Sun; Yi-Bin Hua; Li-Zong Shen
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.